AU4499393A - Novel oxazolidines - Google Patents

Novel oxazolidines

Info

Publication number
AU4499393A
AU4499393A AU44993/93A AU4499393A AU4499393A AU 4499393 A AU4499393 A AU 4499393A AU 44993/93 A AU44993/93 A AU 44993/93A AU 4499393 A AU4499393 A AU 4499393A AU 4499393 A AU4499393 A AU 4499393A
Authority
AU
Australia
Prior art keywords
compounds
novel
denote
adrenoreceptors
inflammations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44993/93A
Other versions
AU672984B2 (en
Inventor
Eric Francotte
Hans-Peter Gschwind
Alfred Sallman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU4499393A publication Critical patent/AU4499393A/en
Application granted granted Critical
Publication of AU672984B2 publication Critical patent/AU672984B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to novel oxazolidine compounds of the formula (I) <IMAGE> in which R1 and R2 simultaneously denote hydrogen, or both denote the same lower alkyl radical or together stand for 4- to 7-membered lower alkylene, and their salts in racemic and chiral form, processes for the preparation of the said compounds, pharmaceutical preparations containing these and their use as pharmaceutical active ingredients. The compounds have a stimulant action on beta-adrenoreceptors and can be used, inter alia, in the treatment of diseases which are associated with reversible airways obstruction, such as e.g. asthma and chronic bronchitis, and also for inflammations of varying origin.
AU44993/93A 1992-09-02 1993-08-30 Novel oxazolidines Ceased AU672984B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2742/92 1992-09-02
CH274292 1992-09-02

Publications (2)

Publication Number Publication Date
AU4499393A true AU4499393A (en) 1994-03-10
AU672984B2 AU672984B2 (en) 1996-10-24

Family

ID=4240593

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44993/93A Ceased AU672984B2 (en) 1992-09-02 1993-08-30 Novel oxazolidines

Country Status (14)

Country Link
US (1) US5369117A (en)
EP (1) EP0586344B1 (en)
JP (1) JP3070812B2 (en)
KR (1) KR100306652B1 (en)
AT (1) ATE170848T1 (en)
AU (1) AU672984B2 (en)
CA (1) CA2105215C (en)
DE (1) DE59308970D1 (en)
DK (1) DK0586344T3 (en)
ES (1) ES2121071T3 (en)
IL (1) IL106862A (en)
NZ (1) NZ248550A (en)
TW (1) TW223065B (en)
ZA (1) ZA936393B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
CA2163399A1 (en) * 1994-11-24 1996-05-25 Katsuhiro Kawano Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
DE2366625C2 (en) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
US4219655A (en) * 1979-07-16 1980-08-26 Stauffer Chemical Company Process for the production of N-acyl substituted oxazolidines
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4705798A (en) * 1985-09-27 1987-11-10 University Of Iowa Research Foundation Phenylephrine prodrug useful as mydriatic agent
US5066793A (en) * 1987-10-26 1991-11-19 Ciba-Geigy Corporation Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids, process for their preparation, and the use thereof

Also Published As

Publication number Publication date
JP3070812B2 (en) 2000-07-31
CA2105215A1 (en) 1994-03-03
EP0586344B1 (en) 1998-09-09
NZ248550A (en) 1995-09-26
TW223065B (en) 1994-05-01
IL106862A0 (en) 1993-12-28
ATE170848T1 (en) 1998-09-15
ZA936393B (en) 1994-03-25
IL106862A (en) 1997-07-13
AU672984B2 (en) 1996-10-24
CA2105215C (en) 2004-06-29
KR940007010A (en) 1994-04-26
JPH06157487A (en) 1994-06-03
US5369117A (en) 1994-11-29
DE59308970D1 (en) 1998-10-15
KR100306652B1 (en) 2001-12-28
ES2121071T3 (en) 1998-11-16
EP0586344A1 (en) 1994-03-09
DK0586344T3 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
FI842615A (en) ANALOGER AV MEVALOLAKTON OCH DERAS DEVIVAT, FOERFARANDE FOER PRODUCERING AV DESSA, DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION OCH DERAS ANVAENDNING.
ATE50256T1 (en) HYPOGLYCEMIC THIAZOLIDINEDIONES.
CA2203274A1 (en) Apolipoprotein-b synthesis inhibitors
FI860878A (en) AMINOSYRADERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
EP0391721A3 (en) Ocular hypotensive agents
FI933719A (en) 4 - ((2-BENSOTIAZOLYL) methylamino) -N - ((3,4-DIFLUORFENOXI) methyl) -1-PIPERIDINETANOL
AU4499393A (en) Novel oxazolidines
GB8829593D0 (en) Novel compounds
SE8904127D0 (en) NEW BIOCYCLIC AMINO-SUBSTITUTED COMPOUNDS
IL81337A (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them
MD1687G2 (en) Arylthiocompounds, pharmaceutical composition, methods of bacterial and viral infections treatment
ES2000907A6 (en) 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
ES499915A1 (en) starting compounds and process for their preparation.
WO1987004435A3 (en) Xanthine compounds
CA2177171A1 (en) Novel substituted oxazolidines